Annual Non Current Assets
$4.51 M
-$1.27 M-22.00%
December 31, 2023
Summary
- As of February 7, 2025, AVIR annual long term assets is $4.51 million, with the most recent change of -$1.27 million (-22.00%) on December 31, 2023.
- During the last 3 years, AVIR annual non current assets has risen by +$4.36 million (+2811.61%).
- AVIR annual non current assets is now -22.00% below its all-time high of $5.79 million, reached on December 31, 2022.
Performance
AVIR Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$4.05 M
+$36.00 K+0.90%
September 30, 2024
Summary
- As of February 7, 2025, AVIR quarterly long term assets is $4.05 million, with the most recent change of +$36.00 thousand (+0.90%) on September 30, 2024.
- Over the past year, AVIR quarterly non current assets has dropped by -$708.00 thousand (-14.88%).
- AVIR quarterly non current assets is now -29.99% below its all-time high of $5.79 million, reached on December 31, 2022.
Performance
AVIR Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
AVIR Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -22.0% | -14.9% |
3 y3 years | +2811.6% | -14.9% |
5 y5 years | +2668.7% | -14.9% |
AVIR Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -22.0% | +822.9% | -30.0% | +728.4% |
5 y | 5-year | -22.0% | +2811.6% | -30.0% | +2513.6% |
alltime | all time | -22.0% | +2811.6% | -30.0% | +2513.6% |
Atea Pharmaceuticals Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $4.05 M(+0.9%) |
Jun 2024 | - | $4.01 M(-5.9%) |
Mar 2024 | - | $4.26 M(-5.5%) |
Dec 2023 | $590.46 M(-10.7%) | $4.51 M(-5.2%) |
Sep 2023 | - | $4.76 M(-8.5%) |
Jun 2023 | - | $5.20 M(-9.4%) |
Mar 2023 | - | $5.74 M(-0.8%) |
Dec 2022 | $660.92 M | $5.79 M(+24.7%) |
Sep 2022 | - | $4.64 M(-5.0%) |
Jun 2022 | - | $4.89 M(+23.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $3.96 M(+709.2%) |
Dec 2021 | $772.40 M(-10.5%) | $489.00 K(-12.4%) |
Sep 2021 | - | $558.00 K(+28.9%) |
Jun 2021 | - | $433.00 K(-14.1%) |
Mar 2021 | - | $504.00 K(+225.2%) |
Dec 2020 | $863.48 M(+3841.0%) | $155.00 K(-90.8%) |
Sep 2020 | - | $1.69 M(+30.7%) |
Jun 2020 | - | $1.29 M(+694.5%) |
Dec 2019 | $21.91 M(-36.9%) | $163.00 K |
Dec 2018 | $34.70 M | - |
FAQ
- What is Atea Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals annual non current assets year-on-year change?
- What is Atea Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly non current assets year-on-year change?
What is Atea Pharmaceuticals annual long term assets?
The current annual non current assets of AVIR is $4.51 M
What is the all time high annual non current assets for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual long term assets is $5.79 M
What is Atea Pharmaceuticals annual non current assets year-on-year change?
Over the past year, AVIR annual long term assets has changed by -$1.27 M (-22.00%)
What is Atea Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of AVIR is $4.05 M
What is the all time high quarterly non current assets for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly long term assets is $5.79 M
What is Atea Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, AVIR quarterly long term assets has changed by -$708.00 K (-14.88%)